Michael Guerrero
About Michael Guerrero
Michael Guerrero serves as the Head of Technical Development at BridgeBio, a position he has held since 2020. He holds a Bachelor's degree in Chemistry and Biochemistry from North Carolina State University and a Ph.D. in Microbiology, Immunology, and Cancer Biology from the University of Virginia.
Work at BridgeBio
Michael Guerrero has been serving as the Head of Technical Development at BridgeBio since 2020. In this role, he oversees the technical aspects of development within the organization. Prior to his current position, he held the role of Head of Process Development - Gene Therapy at BridgeBio from 2019 to 2020. His experience at BridgeBio spans a total of four years, contributing to the company's advancements in biotechnology.
Education and Expertise
Michael Guerrero holds a Doctor of Philosophy (Ph.D.) in Microbiology, Immunology, and Cancer Biology from the University of Virginia, where he studied from 2005 to 2013. He also earned a Bachelor's Degree in Chemistry and a Bachelor's Degree in Biochemistry from North Carolina State University, along with a Minor in English. His educational background provides a strong foundation in both the scientific and technical aspects of biotechnology.
Background in Biotechnology
Before his tenure at BridgeBio, Michael Guerrero worked at FUJIFILM Diosynth Biotechnologies in various roles, including Scientist II and Senior Scientist, from 2015 to 2017. He also served as Head of Upstream Process Development at The Duke Human Vaccine Institute from 2017 to 2019. His experience includes a position as a Consultant in Cell Culture Development at Biogen in 2015 and as a Postdoctoral Research Associate at the University of North Carolina at Chapel Hill from 2013 to 2015.
Professional Experience
Michael Guerrero's professional journey includes significant roles in renowned organizations. He worked as a Graduate Student at the University of Virginia from 2005 to 2013, where he completed his doctoral studies. His career in the biotechnology sector has been marked by positions that emphasize process development and technical expertise, particularly in gene therapy and vaccine development.